留置针、注射器引爆贿赂黑幕，医疗反腐重拳施治

Group 1 - The core issue highlighted is a long-term bribery case involving a sales representative from a medical polymer products company, which has exposed systemic corruption within the healthcare sector, particularly at the Pu'er People's Hospital [1][4] - The bribery network spanned over 15 departments within the hospital, implicating various levels of personnel, including financial directors and clinical department heads, indicating a widespread issue of collective bribery in the medical industry [1][4] - The National Healthcare Security Administration (NHSA) has publicly addressed this case to signal a commitment to tackling corruption by focusing on bribery entities and enforcing legal accountability across the entire chain [1][3] Group 2 - During the "14th Five-Year Plan" period, China has established the largest medical security network globally, significantly reducing the burden of medical expenses for the public and improving overall health levels [3] - Continuous efforts in anti-corruption within the medical sector are seen as crucial for maintaining a healthy industry ecosystem and ensuring the protection of public interests [3][9] - The NHSA has been actively reporting on cases of medical commercial bribery, emphasizing the need for stringent oversight on key positions and processes to strengthen anti-corruption measures [6][9] Group 3 - The bribery case involved a total of over 1.19 million yuan in bribes, with the pediatric department receiving the highest kickbacks, indicating a deep entrenchment of corrupt practices at various levels of hospital operations [5][4] - The NHSA has initiated centralized procurement measures for medical consumables to eliminate inflated pricing and reduce the financial burden on patients, addressing the root causes of corruption in the industry [5][8] - Recent cases of bribery in the medical equipment sector have also been reported, showcasing a broader trend of corruption that the NHSA is actively working to combat [7][8]